These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Antitumour effects and pharmacokinetics of combination of vinblastine with a staurosporine derivative, NA-382, in P388/ADR-bearing mice. Miyamoto K; Takeda K; Koga K; Ohshima T; Wakusawa S J Pharm Pharmacol; 1995 Jun; 47(6):524-9. PubMed ID: 7674138 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo. Miyamoto K; Inoko K; Wakusawa S; Kajita S; Hasegawa T; Takagi K; Koyama M Cancer Res; 1993 Apr; 53(7):1555-9. PubMed ID: 8095855 [TBL] [Abstract][Full Text] [Related]
8. Circumvention of multidrug resistance in P388 murine leukemia cells by a novel inhibitor of cyclic AMP-dependent protein kinase, H-87. Miyamoto K; Wakusawa S; Nakamura S; Koshiura R; Otsuka K; Naito K; Hagiwara M; Hidaka H Cancer Lett; 1990 May; 51(1):37-42. PubMed ID: 2337896 [TBL] [Abstract][Full Text] [Related]
9. Saturable function of P-glycoprotein as a drug-efflux pump in multidrug-resistant tumour cells. Miyamoto KI; Koga-Takeda K; Koga K; Ohshima T; Nomura M J Pharm Pharmacol; 1996 May; 48(5):522-5. PubMed ID: 8799879 [TBL] [Abstract][Full Text] [Related]
10. Effects of isoquinolinesulphonamide compounds on multidrug-resistant P388 cells. Nakamura S; Wakusawa S; Tajima K; Miyamoto K; Hagiwara M; Hidaka H J Pharm Pharmacol; 1993 Apr; 45(4):268-73. PubMed ID: 8098366 [TBL] [Abstract][Full Text] [Related]
11. Reversal of vinblastine resistance by a new staurosporine derivative, NA-382, in P388/ADR cells. Miyamoto K; Wakusawa S; Inoko K; Takagi K; Koyama M Cancer Lett; 1992 Jun; 64(2):177-83. PubMed ID: 1351792 [TBL] [Abstract][Full Text] [Related]
12. Reversal of daunomycin and vinblastine resistance in multidrug-resistant P388 leukemia in vitro through enhanced cytotoxicity by triterpenoids. Hasegawa H; Sung JH; Matsumiya S; Uchiyama M; Inouye Y; Kasai R; Yamasaki K Planta Med; 1995 Oct; 61(5):409-13. PubMed ID: 7480200 [TBL] [Abstract][Full Text] [Related]
13. Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo. Wang L; Kitaichi K; Hui CS; Takagi K; Takagi K; Sakai M; Yokogawa K; Miyamoto KI; Hasegawa T Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):587-93. PubMed ID: 10901387 [TBL] [Abstract][Full Text] [Related]
14. Modulation of subcellular distribution of doxorubicin in multidrug-resistant P388/ADR mouse leukemia cells by the chemosensitizer ((2-isopropyl-1-(4-[3-N-methyl-N-(3,4-dimethoxy-beta- phenethyl)amino]propyloxy)-benzenesulfonyl))indolizine. Jaffrézou JP; Levade T; Chatelain P; Laurent G Cancer Res; 1992 Dec; 52(23):6440-6. PubMed ID: 1423291 [TBL] [Abstract][Full Text] [Related]
15. Effects of ruthenium red on accumulation and cytotoxicity of m-AMSA, vinblastine and daunorubicin in leukemia cells. Wilberding C; Kessel D Biochem Pharmacol; 1984 Aug; 33(16):2559-62. PubMed ID: 6205658 [TBL] [Abstract][Full Text] [Related]
16. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells. Ganapathi R; Reiter W; Krishan A J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267 [TBL] [Abstract][Full Text] [Related]
17. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance. Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210 [TBL] [Abstract][Full Text] [Related]
18. Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate. Wilkoff LJ; Dulmadge EA J Natl Cancer Inst; 1982 Jun; 68(6):1023-6. PubMed ID: 6953266 [TBL] [Abstract][Full Text] [Related]
19. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Goldenberg GJ; Wang H; Blair GW Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020 [TBL] [Abstract][Full Text] [Related]
20. Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models. Trendowski M; Mitchell JM; Corsette CM; Acquafondata C; Fondy TP Invest New Drugs; 2015 Apr; 33(2):290-9. PubMed ID: 25563824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]